Context and biological diversity
Renal carcinomas include clear cell and various non-clear cell histologies. Stage, grade and hereditary context cannot be inferred from the name kidney cancer alone. Comparing studies requires knowing the pathological classification used, whether a sample is primary or metastatic and which treatments preceded it.
What research makes it possible to study
TCGA studied clear cell renal cell carcinoma and described alterations in pathways linked to cellular regulation and metabolism. Integrating different molecular layers helps explore mechanisms and groupings. This cohort does not characterize all renal carcinomas, and a molecular marker associated with outcome needs independent validation.
Application in a research project
A heterogeneity study can compare regions within one tumor with metastasis samples, specifying sampling time and location. Prognostic investigation should distinguish relapse after localized disease from the course of metastatic disease. Loss of adequate tissue and selection of operated cases need to be reported.
Research questions
Is a signature measured in one tumor region stable across regions, and does it retain an association with recurrence?
- Study design
- A study with multiregion sampling and an independent cohort for prognostic validation.
- What to measure
- Molecular agreement between regions, recurrence, added performance and analytical failures.
- Interpretation limits
- Intratumoral heterogeneity may limit an isolated biopsy. Clear cell evidence should not be generalized to other renal histologies.
Interpretation limits
Intratumoral heterogeneity may limit an isolated biopsy. Clear cell evidence should not be generalized to other renal histologies.
Original references
Continue exploring
Research questions
Educational content for framing research. Consult the original document, study population and methodology before interpreting a conclusion. Methodology